Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Medicines Australia Appoints Interim CEO

This article was originally published in Scrip

Executive Summary

Australia's pharmaceutical industry association, Medicines Australia, has appointed Lee Hill as its new interim CEO after its former CEO, Tim James, resigned in December. Mr Hill, who will likely stay in the position until June, has more than 10 years' experience as a "senior business leader," says the association. He has held posts such as CEO or managing director at leading pharmaceutical companies and consultancies. During the next six months he will prepare for a smooth transition for his successor and will work with the association's board to identify the organization's needs for ensuring "long-term success".






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst